Smoking cessation and mortality risk reduction in older adults with long-term smoking history.


Journal

BMC public health
ISSN: 1471-2458
Titre abrégé: BMC Public Health
Pays: England
ID NLM: 100968562

Informations de publication

Date de publication:
14 Oct 2024
Historique:
received: 27 06 2024
accepted: 03 10 2024
medline: 15 10 2024
pubmed: 15 10 2024
entrez: 14 10 2024
Statut: epublish

Résumé

The association between smoking cessation and decreased mortality existed among former smokers has been well documented. However, evidence is limited for smokers with long-term exposure. This study aims to quantify the association between smoking cessation and mortality by years since quitting in older adults with long-term smoking history. Data from Beijing Healthy Aging Cohort Study (BHACS), conducted among communities aged over 55 years old at recruitment, were collected via questionnaire between July 2009 and September 2015 and followed up for all-cause and cancer mortality until March 2021. Self-reported smoking status and years since quitting were collected at baseline. Cox proportional hazards models were used to examine the association between smoking cessation and all-cause and cancer mortality. A total of 11 235 participants (43.9% male) were included, with a mean age of 70.35 (SD 7.71) years. Former smokers comprised 31.7% of the cohort, with a median smoking duration of 43 (IQR: 34-50) years. During 71 573 person-years of follow-up, there were 1 617 deaths (14.4% of the total cohort), of which 872 (17.7%) occurred among male participants. Compared with never smokers, HR (95%CI) for participants who current smoked was 2.898 (2.092-4.013); quit smoking less than 10 years (medians [quartiles] 4 [1, 7] years) before recruitment was 2.738(1.972-3.802); 10 to 20 years (16 [13, 20] years), 1.807(1.286-2.540); and 20 years or more (30 [25, 37] years), 1.293(0.981-1.705). The risk of all-cause and cancer mortality decreased gradually over years since quitting. Quitting less than 10 years, 10 to 20 years and 20 years or more, former smokers avoided an estimated 8.4%, 57.5% and 84.6% of excess all-cause mortality associated with current smoking, respectively. The association between smoking cessation and decreased mortality was observed among former smokers regardless of smoking history. In this study, current smoking was associated with nearly triple the mortality risk compared to never smoking. Smoking cessation, even after a long-term smoking history, was associated with significant decreases in the relative excess mortality linked to continuing smoking. The association were more pronounced in men.

Sections du résumé

BACKGROUND BACKGROUND
The association between smoking cessation and decreased mortality existed among former smokers has been well documented. However, evidence is limited for smokers with long-term exposure. This study aims to quantify the association between smoking cessation and mortality by years since quitting in older adults with long-term smoking history.
METHODS METHODS
Data from Beijing Healthy Aging Cohort Study (BHACS), conducted among communities aged over 55 years old at recruitment, were collected via questionnaire between July 2009 and September 2015 and followed up for all-cause and cancer mortality until March 2021. Self-reported smoking status and years since quitting were collected at baseline. Cox proportional hazards models were used to examine the association between smoking cessation and all-cause and cancer mortality.
RESULTS RESULTS
A total of 11 235 participants (43.9% male) were included, with a mean age of 70.35 (SD 7.71) years. Former smokers comprised 31.7% of the cohort, with a median smoking duration of 43 (IQR: 34-50) years. During 71 573 person-years of follow-up, there were 1 617 deaths (14.4% of the total cohort), of which 872 (17.7%) occurred among male participants. Compared with never smokers, HR (95%CI) for participants who current smoked was 2.898 (2.092-4.013); quit smoking less than 10 years (medians [quartiles] 4 [1, 7] years) before recruitment was 2.738(1.972-3.802); 10 to 20 years (16 [13, 20] years), 1.807(1.286-2.540); and 20 years or more (30 [25, 37] years), 1.293(0.981-1.705). The risk of all-cause and cancer mortality decreased gradually over years since quitting. Quitting less than 10 years, 10 to 20 years and 20 years or more, former smokers avoided an estimated 8.4%, 57.5% and 84.6% of excess all-cause mortality associated with current smoking, respectively. The association between smoking cessation and decreased mortality was observed among former smokers regardless of smoking history.
CONCLUSIONS CONCLUSIONS
In this study, current smoking was associated with nearly triple the mortality risk compared to never smoking. Smoking cessation, even after a long-term smoking history, was associated with significant decreases in the relative excess mortality linked to continuing smoking. The association were more pronounced in men.

Identifiants

pubmed: 39402477
doi: 10.1186/s12889-024-20270-w
pii: 10.1186/s12889-024-20270-w
doi:

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

2821

Subventions

Organisme : National Nature Science Foundation of China
ID : 82173589
Organisme : National Nature Science Foundation of China
ID : 82173590
Organisme : Capital's Funds for Health Improvement and Research
ID : 2022-2G-5031

Informations de copyright

© 2024. The Author(s).

Références

Zhou M, Wang H, Zeng X, Yin P, Zhu J, Chen W, Li X, Wang L, Wang L, Liu Y, et al. Mortality, morbidity, and risk factors in China and its provinces, 1990–2017: a systematic analysis for the global burden of Disease Study 2017. Lancet. 2019;394(10204):1145–58.
doi: 10.1016/S0140-6736(19)30427-1 pubmed: 31248666 pmcid: 6891889
Chan KH, Wright N, Xiao D, Guo Y, Chen Y, Du H, Yang L, Millwood IY, Pei P, Wang J, et al. Tobacco smoking and risks of more than 470 diseases in China: a prospective cohort study. Lancet Public Health. 2022;7(12):e1014–26.
doi: 10.1016/S2468-2667(22)00227-4 pubmed: 36462513 pmcid: 7613927
Reitsma MB, Kendrick PJ, Ababneh E, Abbafati C, Abbasi-Kangevari M, Abdoli A, Abedi A, Abhilash ES, Abila DB, Aboyans V, et al. Spatial, temporal, and demographic patterns in prevalence of smoking tobacco use and attributable disease burden in 204 countries and territories, 1990–2019: a systematic analysis from the global burden of Disease Study 2019. Lancet. 2021;397(10292):2337–60.
doi: 10.1016/S0140-6736(21)01169-7
Lam TH, He Y, Li LS, Li LS, He SF, Liang BQ. Mortality attributable to cigarette smoking in China. JAMA. 1997;278(18):1505–8.
doi: 10.1001/jama.1997.03550180055037 pubmed: 9363970
Lam TH, He Y, Shi QL, Huang JY, Zhang F, Wan ZH, Sun CS, Li LS. Smoking, quitting, and mortality in a Chinese cohort of retired men. Ann Epidemiol. 2002;12(5):316–20.
doi: 10.1016/S1047-2797(01)00258-7 pubmed: 12062918
He Y, Jiang B, Li LS, Li LS, Sun DL, Wu L, Liu M, He SF, Liang BQ, Hu FB, et al. Changes in smoking behavior and subsequent mortality risk during a 35-year follow-up of a cohort in Xi’an, China. Am J Epidemiol. 2014;179(9):1060–70.
doi: 10.1093/aje/kwu011 pubmed: 24674900
Zhang M, Yang L, Wang L, Jiang Y, Huang Z, Zhao Z, Zhang X, Li Y, Liu S, Li C, et al. Trends in smoking prevalence in urban and rural China, 2007 to 2018: findings from 5 consecutive nationally representative cross-sectional surveys. PLoS Med. 2022;19(8):e1004064.
doi: 10.1371/journal.pmed.1004064 pubmed: 36006870 pmcid: 9409540
Jha P, Ramasundarahettige C, Landsman V, Rostron B, Thun M, Anderson RN, McAfee T, Peto R. 21st-century hazards of smoking and benefits of cessation in the United States. N Engl J Med. 2013;368(4):341–50.
doi: 10.1056/NEJMsa1211128 pubmed: 23343063
Thun MJ, Carter BD, Feskanich D, Freedman ND, Prentice R, Lopez AD, Hartge P, Gapstur SM. 50-year trends in smoking-related mortality in the United States. N Engl J Med. 2013;368(4):351–64.
doi: 10.1056/NEJMsa1211127 pubmed: 23343064 pmcid: 3632080
Doll R, Peto R, Boreham J, Sutherland I. Mortality in relation to smoking: 50 years’ observations on male British doctors. BMJ. 2004;328(7455):1519.
doi: 10.1136/bmj.38142.554479.AE pubmed: 15213107 pmcid: 437139
Pirie K, Peto R, Reeves GK, Green J, Beral V. The 21st century hazards of smoking and benefits of stopping: a prospective study of one million women in the UK. Lancet. 2013;381(9861):133–41.
doi: 10.1016/S0140-6736(12)61720-6 pubmed: 23107252 pmcid: 3547248
Jha P. The hazards of smoking and the benefits of cessation: a critical summation of the epidemiological evidence in high-income countries. Elife 2020, 9.
Chen Z, Peto R, Zhou M, Iona A, Smith M, Yang L, Guo Y, Chen Y, Bian Z, Lancaster G, et al. Contrasting male and female trends in tobacco-attributed mortality in China: evidence from successive nationwide prospective cohort studies. Lancet. 2015;386(10002):1447–56.
doi: 10.1016/S0140-6736(15)00340-2 pubmed: 26466050 pmcid: 4691901
Yang JJ, Yu D, Shu XO, Wen W, Rahman S, Abe S, Saito E, Gupta PC, He J, Tsugane S, et al. Reduction in total and major cause-specific mortality from tobacco smoking cessation: a pooled analysis of 16 population-based cohort studies in Asia. Int J Epidemiol. 2022;50(6):2070–81.
doi: 10.1093/ije/dyab087 pubmed: 34999862
Chen X, Giles J, Yao Y, Yip W, Meng Q, Berkman L, Chen H, Chen X, Feng J, Feng Z, et al. The path to healthy ageing in China: a Peking University-Lancet Commission. Lancet. 2022;400(10367):1967–2006.
doi: 10.1016/S0140-6736(22)01546-X pubmed: 36423650 pmcid: 9801271
Wei Y, Lv Y, Zhou J, Gao X, Duan J, Zhao C, Yin Z, Kang Q, Wu B, Chen C, et al. Smoking cessation in late life is associated with increased risk of all-cause mortality amongst oldest old people: a community-based prospective cohort study. Age Ageing. 2021;50(4):1298–305.
doi: 10.1093/ageing/afaa280 pubmed: 33492360
Liu M, Yang J, Wang C, Yang S, Wang J, Hou C, Wang S, Li X, Li F, Yang H et al. Cohort profile: Beijing Healthy Aging Cohort Study (BHACS). Eur J Epidemiol 2024.
Thomson B, Islami F. Association of Smoking Cessation and Cardiovascular, Cancer, and respiratory mortality. JAMA Intern Med 2023.
Cao Y, Kenfield S, Song Y, Rosner B, Qiu W, Sesso HD, Gaziano JM, Ma J. Cigarette smoking cessation and total and cause-specific mortality: a 22-year follow-up study among US male physicians. Arch Intern Med. 2011;171(21):1956–9.
doi: 10.1001/archinternmed.2011.539 pubmed: 22123811 pmcid: 3229033
Kenfield SA, Stampfer MJ, Rosner BA, Colditz GA. Smoking and smoking cessation in relation to mortality in women. JAMA. 2008;299(17):2037–47.
doi: 10.1001/jama.299.17.2037 pubmed: 18460664 pmcid: 2879642
Yang JJ, Yu D, Wen W, Shu XO, Saito E, Rahman S, Gupta PC, He J, Tsugane S, Xiang YB, et al. Tobacco Smoking and Mortality in Asia: a pooled Meta-analysis. JAMA Netw Open. 2019;2(3):e191474.
doi: 10.1001/jamanetworkopen.2019.1474 pubmed: 30924901 pmcid: 6450311
Yang JJ, Yu D, Shu XO, Freedman ND, Wen W, Rahman S, Abe SK, Saito E, Gupta PC, He J, et al. Quantifying the association of low-intensity and late initiation of tobacco smoking with total and cause-specific mortality in Asia. Tob Control. 2021;30(3):328–35.
doi: 10.1136/tobaccocontrol-2019-055412 pubmed: 32546664
Lam TH. Absolute risk of tobacco deaths: one in two smokers will be killed by smoking: comment on smoking and all-cause mortality in older people. Arch Intern Med. 2012;172(11):845–6.
doi: 10.1001/archinternmed.2012.1927 pubmed: 22688993
Lam TH, Xu L, Jiang CQ, Zhang WS, Zhu F, Jin YL, Thomas GN, Cheng KK. High relative risk of all-cause mortality attributed to smoking in China: Guangzhou Biobank Cohort Study. PLoS ONE. 2018;13(4):e0196610.
doi: 10.1371/journal.pone.0196610 pubmed: 29698485 pmcid: 5919701
Mons U, Müezzinler A, Gellert C, Schöttker B, Abnet CC, Bobak M, de Groot L, Freedman ND, Jansen E, Kee F, et al. Impact of smoking and smoking cessation on cardiovascular events and mortality among older adults: meta-analysis of individual participant data from prospective cohort studies of the CHANCES consortium. BMJ. 2015;350:h1551.
doi: 10.1136/bmj.h1551 pubmed: 25896935 pmcid: 4413837
Müezzinler A, Mons U, Gellert C, Schöttker B, Jansen E, Kee F, O’Doherty MG, Kuulasmaa K, Freedman ND, Abnet CC, et al. Smoking and all-cause mortality in older adults: results from the CHANCES Consortium. Am J Prev Med. 2015;49(5):e53–63.
doi: 10.1016/j.amepre.2015.04.004 pubmed: 26188685
Mai ZM, Ho SY, Lo CM, Wang MP, Peto R, Lam TH. Mortality reduction from quitting smoking in Hong Kong: population-wide proportional mortality study. Int J Epidemiol. 2018;47(3):752–9.
doi: 10.1093/ije/dyx267 pubmed: 29438481
Lim SH, Tai BC, Yuan JM, Yu MC, Koh WP. Smoking cessation and mortality among middle-aged and elderly Chinese in Singapore: the Singapore Chinese Health Study. Tob Control. 2013;22(4):235–40.
doi: 10.1136/tobaccocontrol-2011-050106 pubmed: 22170337
Lam TH, Li ZB, Ho SY, Chan WM, Ho KS, Tham MK, Cowling BJ, Schooling CM, Leung GM. Smoking, quitting and mortality in an elderly cohort of 56,000 Hong Kong Chinese. Tob Control. 2007;16(3):182–9.
doi: 10.1136/tc.2006.019505 pubmed: 17565138 pmcid: 2598507
Hu Y, Zong G, Liu G, Wang M, Rosner B, Pan A, Willett WC, Manson JE, Hu FB, Sun Q. Smoking Cessation, Weight Change, Type 2 Diabetes, and Mortality. NEJM 2018;379(7):623–632.
Liu G, Hu Y, Zong G, Pan A, Manson JE, Rexrode KM, Rimm EB, Hu FB, Sun Q. Smoking cessation and weight change in relation to cardiovascular disease incidence and mortality in people with type 2 diabetes: a population-based cohort study. Lancet Diabetes Endocrinol. 2020;8(2):125–33.
doi: 10.1016/S2213-8587(19)30413-9 pubmed: 31924561 pmcid: 6986932
Sahle BW, Chen W, Rawal LB, Renzaho AMN. Weight Gain after Smoking Cessation and Risk of Major Chronic diseases and Mortality. JAMA Netw Open. 2021;4(4):e217044.
doi: 10.1001/jamanetworkopen.2021.7044 pubmed: 33904915 pmcid: 8080225
Green MJ. Potential biases when observing increased mortality risk in association with smoking cessation among older adults. Age Ageing. 2021;50(4):1069–70.
doi: 10.1093/ageing/afab041 pubmed: 33677511

Auteurs

Shimin Chen (S)

Graduate School, Chinese PLA General Hospital & Chinese PLA Medical Academy, No.28 Fuxing Road, Haidian District, Beijing, 100853, China.
Institute of Geriatrics, Beijing Key Laboratory of Aging and Geriatrics, National Clinical Research Center for Geriatrics Diseases, Second Medical Center, Chinese PLA General Hospital, No.28 Fuxing Road, Haidian District, Beijing, 100853, China.

Shanshan Yang (S)

Department of Disease Prevention and Control, First Medical Center, Chinese PLA General Hospital, Beijing, 100853, China.

Shengshu Wang (S)

Institute of Geriatrics, Beijing Key Laboratory of Aging and Geriatrics, National Clinical Research Center for Geriatrics Diseases, Second Medical Center, Chinese PLA General Hospital, No.28 Fuxing Road, Haidian District, Beijing, 100853, China.

Haowei Li (H)

Institute of Geriatrics, Beijing Key Laboratory of Aging and Geriatrics, National Clinical Research Center for Geriatrics Diseases, Second Medical Center, Chinese PLA General Hospital, No.28 Fuxing Road, Haidian District, Beijing, 100853, China.

Rongrong Li (R)

Institute of Geriatrics, Beijing Key Laboratory of Aging and Geriatrics, National Clinical Research Center for Geriatrics Diseases, Second Medical Center, Chinese PLA General Hospital, No.28 Fuxing Road, Haidian District, Beijing, 100853, China.

Huaihao Li (H)

Institute of Geriatrics, Beijing Key Laboratory of Aging and Geriatrics, National Clinical Research Center for Geriatrics Diseases, Second Medical Center, Chinese PLA General Hospital, No.28 Fuxing Road, Haidian District, Beijing, 100853, China.

Yueting Shi (Y)

Institute of Geriatrics, Beijing Key Laboratory of Aging and Geriatrics, National Clinical Research Center for Geriatrics Diseases, Second Medical Center, Chinese PLA General Hospital, No.28 Fuxing Road, Haidian District, Beijing, 100853, China.

Junhan Yang (J)

Institute of Geriatrics, Beijing Key Laboratory of Aging and Geriatrics, National Clinical Research Center for Geriatrics Diseases, Second Medical Center, Chinese PLA General Hospital, No.28 Fuxing Road, Haidian District, Beijing, 100853, China.

Yinghui Bao (Y)

Institute of Geriatrics, Beijing Key Laboratory of Aging and Geriatrics, National Clinical Research Center for Geriatrics Diseases, Second Medical Center, Chinese PLA General Hospital, No.28 Fuxing Road, Haidian District, Beijing, 100853, China.

Shengyan Du (S)

Institute of Geriatrics, Beijing Key Laboratory of Aging and Geriatrics, National Clinical Research Center for Geriatrics Diseases, Second Medical Center, Chinese PLA General Hospital, No.28 Fuxing Road, Haidian District, Beijing, 100853, China.

Min Zhao (M)

Institute of Geriatrics, Beijing Key Laboratory of Aging and Geriatrics, National Clinical Research Center for Geriatrics Diseases, Second Medical Center, Chinese PLA General Hospital, No.28 Fuxing Road, Haidian District, Beijing, 100853, China.

Wenchang Wang (W)

Institute of Geriatrics, Beijing Key Laboratory of Aging and Geriatrics, National Clinical Research Center for Geriatrics Diseases, Second Medical Center, Chinese PLA General Hospital, No.28 Fuxing Road, Haidian District, Beijing, 100853, China.

Jianhua Wang (J)

Institute of Geriatrics, Beijing Key Laboratory of Aging and Geriatrics, National Clinical Research Center for Geriatrics Diseases, Second Medical Center, Chinese PLA General Hospital, No.28 Fuxing Road, Haidian District, Beijing, 100853, China.

Miao Liu (M)

Graduate School, Chinese PLA General Hospital & Chinese PLA Medical Academy, No.28 Fuxing Road, Haidian District, Beijing, 100853, China. liumiaolmbxb@163.com.

Yao He (Y)

Institute of Geriatrics, Beijing Key Laboratory of Aging and Geriatrics, National Clinical Research Center for Geriatrics Diseases, Second Medical Center, Chinese PLA General Hospital, No.28 Fuxing Road, Haidian District, Beijing, 100853, China. yhe301@sina.com.
State Key Laboratory of Kidney Diseases, Beijing, 100853, China. yhe301@sina.com.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH